NEW YORK (GenomeWeb) – Perthera said today that it is partnering with stomach cancer non-profit Hope for Stomach Cancer to provide its Precision Cancer Analysis (PCA) service to all HSC patients at no cost to them.

Through its PCA service, Perthera will facilitate molecular profiling of Hope for Stomach Cancer patients, providing genomic, proteomic, and phosphoproteomic analyses of their tumors along with treatment recommendations based upon this molecular information.

Financial and other terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.